Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M9,222Revenue $M1,325Net Margin (%)24.9Altman Z-Score4.4
Enterprise Value $M9,438EPS $5.2Operating Margin %38.4Piotroski F-Score7
P/E(ttm)29.2Beneish M-Score-2.6Pre-tax Margin (%)32.9Higher ROA y-yY
Price/Book5.910-y EBITDA Growth Rate %--Quick Ratio5.5Cash flow > EarningsY
Price/Sales7.35-y EBITDA Growth Rate %36.9Current Ratio5.6Lower Leverage y-yY
Price/Free Cash Flow19.4y-y EBITDA Growth Rate %87.0ROA % (ttm)9.8Higher Current Ratio y-yY
Dividend Yield %--PEG0.8ROE % (ttm)22.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M60.4ROIC % (ttm)20.3Gross Margin Increase y-yY

Gurus Latest Trades with JAZZ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JAZZKen Fisher 2016-03-31 Add$112.72 - $140.56
($124.56)
$ 152.5722%Add 4.84%1,949
JAZZNWQ Managers 2015-12-31 Sold Out -0.25%$121.94 - $150.45
($138.92)
$ 152.5710%Sold Out0
JAZZJoel Greenblatt 2015-12-31 Add0.24%$121.94 - $150.45
($138.92)
$ 152.5710%Add 620.48%184,961
JAZZGeorge Soros 2015-12-31 Buy 0.01%$121.94 - $150.45
($138.92)
$ 152.5710%New holding3,200
JAZZKen Fisher 2015-12-31 Add$121.94 - $150.45
($138.67)
$ 152.5710%Add 7.77%1,859
JAZZJoel Greenblatt 2015-09-30 Add0.03%$124.46 - $193.02
($172.53)
$ 152.57-12%Add 620.11%25,672
JAZZNWQ Managers 2015-09-30 Reduce-0.01%$124.46 - $193.02
($172.53)
$ 152.57-12%Reduce -2.34%123,720
JAZZKen Fisher 2015-09-30 Add$124.46 - $193.02
($172.53)
$ 152.57-12%Add 32.69%1,725
JAZZSteve Mandel 2015-06-30 Sold Out -0.17%$167.87 - $189.92
($179.49)
$ 152.57-15%Sold Out0
JAZZNWQ Managers 2015-06-30 Add0.15%$167.87 - $189.92
($179.49)
$ 152.57-15%Add 95.42%126,680
JAZZJoel Greenblatt 2015-06-30 Reduce-0.01%$167.87 - $189.92
($179.49)
$ 152.57-15%Reduce -67.22%3,565
JAZZSteve Mandel 2015-03-31 Reduce-1.12%$158.12 - $189.01
($171.62)
$ 152.57-11%Reduce -86.14%260,985
JAZZJoel Greenblatt 2015-03-31 Buy 0.01%$158.12 - $189.01
($171.62)
$ 152.57-11%New holding10,874
JAZZNWQ Managers 2015-03-31 Add$158.12 - $189.01
($171.62)
$ 152.57-11%Add 0.06%64,824
JAZZKen Fisher 2015-03-31 Buy $158.12 - $189.01
($171.62)
$ 152.57-11%New holding1,300
JAZZNWQ Managers 2014-12-31 Reduce-0.13%$142.72 - $183.03
($166.14)
$ 152.57-8%Reduce -53.29%64,783
JAZZSteve Mandel 2014-09-30 Reduce-0.17%$132.55 - $174.37
($153.67)
$ 152.57-1%Reduce -14.30%1,788,607
JAZZNWQ Managers 2014-09-30 Reduce-0.1%$132.55 - $174.37
($153.67)
$ 152.57-1%Reduce -32.97%138,705
JAZZSteve Mandel 2014-06-30 Reduce-0.15%$124.63 - $154.82
($138.55)
$ 152.5710%Reduce -10.98%2,087,127
JAZZJoel Greenblatt 2014-06-30 Sold Out -0.02%$124.63 - $154.82
($138.55)
$ 152.5710%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JAZZ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


JAZZ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WILSON KAREN JSVP, Finance & PAO 2016-04-25Sell604$160-4.64view
MILLER MICHAEL PATRICKSVP, US Commercial 2016-04-15Sell100$145.794.65view
WILSON KAREN JSVP, Finance & PAO 2016-04-13Sell5,007$1501.71view
Cox Russell J.EVP & COO 2016-04-12Sell4,000$136.9811.38view
WILSON KAREN JSVP, Finance & PAO 2016-04-07Sell2,161$140.98.28view
MILLER MICHAEL PATRICKSVP, US Commercial 2016-03-15Sell100$129.1718.12view
COZADD BRUCE CChairman & CEO 2016-03-08Sell2,500$126.0421.05view
Treacy PaulSVP, Technical Operations 2016-02-29Sell354$123.4823.56view
Mulligan SeamusDirector 2016-02-23Sell27,968$122.7124.33view
MILLER MICHAEL PATRICKSVP, US Commercial 2016-02-16Sell100$115.6331.95view

Quarterly/Annual Reports about JAZZ:

News about JAZZ:

Articles On GuruFocus.com
Citigroup, Amgen Are Trading With Wide Margin of Safety Mar 30 2016 
Weekly Insider Sells Highlight: MHK, JAZZ, BMY, ZAYO Mar 23 2015 
Pharmaceutical Giant Merck Buys Cubist Pharma Dec 09 2014 
Growth Momentum Should Continue For This Pharmaceutical Company Nov 15 2014 
Jazz Pharmaceuticals: Growth Trajectory Can Continue In Future Sep 03 2014 
Weekly CFO Sells Highlight: Google Inc, Jazz Pharmaceuticals PLC, Jack in the Box Inc. Jun 30 2014 
Weekly Insider Sells Highlight: JAZZ, HD, ESRX, SCI Mar 11 2014 
Weekly CFO Sells Highlight: Jazz Pharmaceuticals PLC, Carnival PLC, Juniper Networks Inc., Home Depo Mar 10 2014 
Jazz Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 08 2011 
Jazz Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 05 2010 

More From Other Websites
How Did Jazz Pharmaceuticals’ Products Perform in 2015? Apr 26 2016
What Do Analysts Recommend for Jazz Pharmaceuticals? Apr 26 2016
Jazz Pharmaceuticals to Report 2016 First Quarter Financial Results on May 10, 2016 Apr 26 2016
Jazz Pharmaceuticals to Report 2016 First Quarter Financial Results on May 10, 2016 Apr 26 2016
Can Xyrem Maintain Leadership in the Narcolepsy Space? Apr 26 2016
Jazz Pharma upgraded by Sun Trust Rbsn Humphrey Apr 25 2016
Jazz Pharmaceuticals: How Does Its Earnings Multiple Compare? Apr 21 2016
Why Does Jazz Pharmaceuticals Have a Lower Valuation Than Peers? Apr 21 2016
Valeant CEO Is Brave; Clovis PT Slashed; Buy Jazz ‘Aggressively’? Apr 13 2016
[$$] Four Buys After the Specialty-Pharma Selloff Apr 08 2016
Final Trade: KB Homes, Jazz Pharmaceuticals, & more Apr 07 2016
The Allergan 'Dating Game' Apr 06 2016
Jazz Pharmaceuticals Plc – Value Analysis (NASDAQ:JAZZ) : April 1, 2016 Apr 01 2016
Jazz's Hepatic VOD Drug Defitelio Gains FDA Nod, Shares Up Mar 31 2016
Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : JAZZ-US : March... Mar 31 2016
Citigroup, Amgen Are Trading With Wide Margin of Safety Mar 30 2016
Jazz Pharmaceuticals Announces Webcast for Defitelio® (defibrotide sodium) Investor Update Mar 30 2016
Jazz Pharmaceuticals Announces FDA Approval of Defitelio® (defibrotide sodium) for the Treatment of... Mar 30 2016
Jazz Pharmaceuticals Announces Webcast for Defitelio® (defibrotide sodium) Investor Update Mar 30 2016
Jazz Pharmaceuticals Announces FDA Approval of Defitelio® (defibrotide sodium) for the Treatment of... Mar 30 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)